On February 20, 2026, following the results of the AIPM vote, the Chairman and Vice-Chairman of the Association’s Board of Directors were re-elected. The selected candidates will continue to serve in their posts for the next two years.
The following powers came into force since February 21, 2026:
• Katerina Pogodina (Johnson & Johnson Innovative Medicine Russia & CIS) — Chairman of AIPM Board of Directors;
• Nikita Ivanov (Pfizer Russia & Belarus) — Vice-Chairman of AIPM Board of Directors.
"I am pleased to have the opportunity to continue my work as the elected Chairman of the Board of Directors of the Association of International Pharmaceutical Manufacturers. In my opinion, our policy of cooperation both with the regulator and within the industry, including with other relevant associations, is bearing fruit. Our goal is to develop sustainable access to treatment for Russian patients, helping to achieve key indicators of the national development goals of the Russian Federation. We intend to continue working in this direction, involving more interested parties in the dialogue," comments Katerina Pogodina, AIPM Board of Directors Chairman, Managing Director Johnson & Johnson Innovative Medicine Russia & CIS.
Nikita Ivanov, AIPM Board of Directors Vice-Chairman, General Manager Pfizer Russia & Belarus: "It is a great honor for me to continue my work as Vice-Chairman of the AIPM Board of Directors. We intend to further develop a constructive dialogue with regulators in order to jointly find solutions that really improve the accessibility and quality of care for patients."
The Board of Directors will continue to monitor the activities of the Association, which brings together leading pharmaceutical companies with a shared goal: to ensure patients have access to innovative, high-quality, and safe medicines. AIPM champion the highest standards in quality, ethics, and scientific development, contributing to the advancement of both the pharmaceutical industry and the broader healthcare system.
The following powers came into force since February 21, 2026:
• Katerina Pogodina (Johnson & Johnson Innovative Medicine Russia & CIS) — Chairman of AIPM Board of Directors;
• Nikita Ivanov (Pfizer Russia & Belarus) — Vice-Chairman of AIPM Board of Directors.
"I am pleased to have the opportunity to continue my work as the elected Chairman of the Board of Directors of the Association of International Pharmaceutical Manufacturers. In my opinion, our policy of cooperation both with the regulator and within the industry, including with other relevant associations, is bearing fruit. Our goal is to develop sustainable access to treatment for Russian patients, helping to achieve key indicators of the national development goals of the Russian Federation. We intend to continue working in this direction, involving more interested parties in the dialogue," comments Katerina Pogodina, AIPM Board of Directors Chairman, Managing Director Johnson & Johnson Innovative Medicine Russia & CIS.
Nikita Ivanov, AIPM Board of Directors Vice-Chairman, General Manager Pfizer Russia & Belarus: "It is a great honor for me to continue my work as Vice-Chairman of the AIPM Board of Directors. We intend to further develop a constructive dialogue with regulators in order to jointly find solutions that really improve the accessibility and quality of care for patients."
The Board of Directors will continue to monitor the activities of the Association, which brings together leading pharmaceutical companies with a shared goal: to ensure patients have access to innovative, high-quality, and safe medicines. AIPM champion the highest standards in quality, ethics, and scientific development, contributing to the advancement of both the pharmaceutical industry and the broader healthcare system.